Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Buminafos

Buminafos

51249-05-9

DISCOVER
Brassinolide

Brassinolide

72962-43-7

DISCOVER
Barbituric acid, Reagentplus

Barbituric acid, Reagentplus

67-52-7

DISCOVER
Bromchlorbuterol hydrochloride

Bromchlorbuterol hydrochloride

78982-84-0

DISCOVER
Betamethasone Dipropionate EPImpurity

Betamethasone Dipropionate EPImpurity

66917-44-0

DISCOVER
Betamethasone Dipropionate EPImpurity J

Betamethasone Dipropionate EPImpurity J

66917-44-0

DISCOVER
Cyclodextrin-beta

Cyclodextrin-beta

7585-39-9

DISCOVER
(R)-Hydroxy Des(boric Acid) Bortezomib

(R)-Hydroxy Des(boric Acid) Bortezomib

289472-78-2

DISCOVER
(S,R)-Hydroperoxy Des(boric Acid) Bortezomib

(S,R)-Hydroperoxy Des(boric Acid) Bortezomib

886979-78-8

DISCOVER
Cetrimide

Cetrimide

1119-97-7

DISCOVER
Carmustine

Carmustine

154-93-8

DISCOVER
Chlorambucil

Chlorambucil

305-03-3

DISCOVER